Compare Deutsche Bank AG (DB) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deutsche Bank AG vs Johnson & Johnson — how do they compare? Deutsche Bank AG trades at $38.31 (market cap $71.96B), while Johnson & Johnson trades at $258.81 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 8.7× Deutsche Bank AG's market cap, and Deutsche Bank AG pays the higher dividend (3.04%). Which is the better fit depends on your goals.
| DB | JNJ | |
|---|---|---|
Market Cap | $71.96B | $626.09B |
Sector | Financials | Health |
52-Week High | $40.33 | $267.24 |
52-Week Low | $28.37 | $172.78 |
Dividend Yield | 3.04% | 2.06% |
Volume | — | 6,156,228 |
Enterprise Value | — | $654.37B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Deutsche Bank AG
In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.
Read more on DB →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
